Nick Haft
Co-Founder, Delix and Managing Director at OMX Ventures
Nick is a Managing Director at OMX Ventures. Prior to OMX, Nick was the sole managing partner at Arcos Ventures, where he deployed over $80M of capital into 20+ bio-related companies. Some of Nick’s prior investments include Finch Therapeutics, Pendulum Therapeutics, Ginkgo Bioworks, 10X Genomics, Imagen, Compass Pathways and many others. He holds a Bachelor of Science in Economics from the Wharton School at the University of Pennsylvania.